Literature DB >> 31066563

Visible-Light-Photocatalyzed Reductions of N-Heterocyclic Nitroaryls to Anilines Utilizing Ascorbic Acid Reductant.

Aleksandar R Todorov1, Santeri Aikonen1, Mikko Muuronen1, Juho Helaja1.   

Abstract

A photoreductive protocol utilizing [Ru(bpy)3]2+ photocatalyst, blue light LEDs, and ascorbic acid (AscH2) has been developed to reduce nitro N-heteroaryls to the corresponding anilines. Based on experimental and computational results and previous studies, we propose that the reaction proceeds via proton-coupled electron transfer between AscH2, photocatalyst, and the nitro N-heteroaryl. The method offers a green catalytic procedure to reduce, e.g., 4-/8-nitroquinolines to the corresponding aminoquinolines, substructures present in important antimalarial drugs.

Entities:  

Year:  2019        PMID: 31066563      PMCID: PMC6750875          DOI: 10.1021/acs.orglett.9b01205

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


Reduction of an aromatic nitro compound is a prototypical way to prepare arylamines that are common substructures in pharmaceuticals, agrochemicals, dyes, and pigments and in a variety of other fine and specialty chemicals.[1] This fundamental transformation can be performed using a plethora of synthetic and catalytic protocols: conventional stoichiometric reagents, e.g., SnCl2, TiCl3, Raney Ni, Zn, Sn, Fe, and Na2S, are appropriate for specific lab-scale conversion,[2] while transition-metal-catalyzed hydrogenations (e.g., Pd, Au, and Pt on various supports: C, TiO2, etc.) dominate industrial applications.[3] Lately, heterogeneous photocatalytic nitroarene reductions on various materials, e.g., semiconductors, nanoparticles, and nanocomposites, have also been under intensive development.[4] Recent advances in photoredox catalysis (e.g., metal complexes and organic dyes) have enabled new strategies for reductive organic conversions.[5] The early photoreductions of nitrobenzenes to anilines were carried out under intense xenon lamp irradiation including UV wavelengths. In a pioneering example, Fukuzumi and co-workers used an excess of dihydroacridine as a reductant for triplet excited PhNO2 in the presence of HClO4/H2O additives in MeCN.[6] Later on, Hirao and co-workers developed a more convenient method, exploiting a Ru(bpy)2(MeCN)2(PF6)2 photosensitizer and hydrazine as reductant, while the most intense UV light was filtered out (<300 nm).[7] Ananthakrishnan and co-workers employed visible light in 4-nitrophenol photoreduction using resin-supported eosin Y with a large excess of NaBH4 (Scheme a).[8] Tung and co-workers developed the method further to extend the substrate scope by utilizing green light-emitting diodes (LEDs) as a light source, eosin Y as a photosensitizer, and triethanolamine (TEOA) as a reductant (Scheme b).[9]
Scheme 1

Visible Light Nitroaryl Photoreduction Reduction Protocols

Our interest has been in the development of catalytic methods for quinoline modifications. Previously, we developed a protocol for photoreductive removal of O-benzyl groups from oxyarene N-heterocycles.[10] At the beginning of the current study, we observed that even the eosin Y/TEOA photoreduction protocol (Scheme b) was widely tolerant for nitrophenyl functional groups, the method was incompatible with nitroquinolines (Table S7). Therefore, we developed here a photocatalytic protocol for reducing nitro groups in N-(oxo)heterocyclic nitroaryls (Scheme c) leading to aminoquinoline structures present in many important antimalarial pharmaceuticals, e.g., in traditional chloroquine[11] and primaquine[12] as well as recently FDA-approved tafenoquine[13] (Figure ).
Figure 1

Examples of 4-/8-aminoquinoline-containing antimalarial drugs.

Examples of 4-/8-aminoquinoline-containing antimalarial drugs. First, we studied the photoreduction of 2-methoxy-6-nitroquinoline 1a in the presence of ascorbic acid (AscH2) as the reductant and Ru(bpy)3Cl2 as the photosensitizer according to earlier successful protocols for reductions by us and others.[14] Optimization of the reaction conditions, i.e., photocatalyst, reductant amount, solvent, concentration, and reaction time, provided aniline 2a with 83% yield after 1 h irradiation with blue LEDs light (455 nm) in the presence of 4 equiv of AscH2 and 1 mol % of the [Ru] catalyst in MeOH/H2O (0.02 M) at rt (Tables S1–S7). Varying the reaction conditions from the optimal shows that reaction does not take place without light, AscH2, or photocatalyst and the reaction is sensitive to air atmosphere (entries 2, 8, 4, and 3 Table ). The reaction was also sensitive to the amount of reactants (entries 5, 9, and 10), and interestingly, the optimal solvent compositions proved to be 4:1 MeOH/H2O and 1:1 EtOH/H2O. The reaction proceeds poorly or not at all in polar aprotic solvents, e.g., DMF and MeCN, even though MeCN was employed as solvent in the previous AscH2 and [Ru]-photocatalyst studies.[14]
Table 1

Effect of Deviation from Standard Reaction Conditionsa

entryvariation from standard conditionsyieldb (%)
1none83 (82)c
2no light0
3air atmosphere28
4no photocatalyst0
50.5% [Ru] loading52
6(Ir[dF(CF3)ppy]2(dtbbpy))PF6 (1 mol %)28
7[Ir(dtbbpy)(ppy)2]PF6 (1 mol %)16
8no AscH20
9AscH2 (2 equiv)18
10AscH2 (3 equiv)79
11Na-ascorbate instead of AscH20
1230 min reaction time36
13MeOH29
14MeOH/H2O (10:1)41
15MeOH/H2O (6:1)62
16MeOH/H2O (2:1)71
17EtOH/H2O (1:1)81
18AcOH additive (10 vol %)58
19DMF11
20MeCN0

Full reaction optimization in Tables S1–S7.

GC yield: average of two runs.

Isolated yield by SiO2 column chromatography

Full reaction optimization in Tables S1–S7. GC yield: average of two runs. Isolated yield by SiO2 column chromatography Next, we studied the scope of the reaction (Scheme ); reduction of nitromethoxyquinolines 1b–1f to the corresponding amines 2b–2f required slightly longer reactions times, 1.5–5 h, depending on the substituent positions. The obtained yields were, however, still high (86–97%) with 2d being an exception by producing unidentified polymeric side products. The excellent yield of 2f demonstrates that halogen substituents in the nitro/amino aryl ring are also well tolerated. In addition, the monosubstituted 5-, 6-, 7-, or 8-nitroquinolines are converted into amines 2g–2j with up to quantitative yields, and the 2-methyl substituent improved the 8-aminoquinoline yield from 75 to 90% (2g vs 2k). Importantly, the protocol proved to be scalable: reduction of 1e on a larger 4 mmol (vs 0.2 mmol) scale with reduced catalyst loading ([Ru] 0.5 mol %) yielded 73% of 2e after 24 h reaction time.
Scheme 2

Reaction Scope Study

Average isolated yields of two runs after SiO2 chromatography.

Up-scaled (4 mmol) reaction under the same light source, 0.5 mol % of [Ru] catalyst.

Reaction Scope Study

Average isolated yields of two runs after SiO2 chromatography. Up-scaled (4 mmol) reaction under the same light source, 0.5 mol % of [Ru] catalyst. A poor yield of 16% received for 2l indicates that the combination of 6-nitro-8-ether substitution is unfavorable for the reaction. On the other hand, 2-methyl-8-nitroquinolines with allyl ether, acyl, or triflyl at the 6-position gave high yields of 83%, 91%, and 96% for 2m, 2n, and 2o, respectively, although the TfO compound (2o) required longer reaction time (7.5 h). The chemoselectivity of the method was further highlighted with a 79% yield of 6-alkyne-substituted 8-amino-4-methoxyquinone 2p after 23 h reaction time. Another attractive class of target molecules is 4-nitroquinolines (Scheme ), which are commonly prepared by nitration of N-oxoquinolines and require the use of trivalent phosphorus compounds for removal of the N-oxo groups.[15] Our received yields of 57%, 35%, and 25% for 2q, 2i, and 2j, respectively, using N-oxo compounds as starting materials are therefore highly encouraging. Last, we also tested the substrate scope for producing 6-aminoisoquinoline 2r and 5-aminobenzothiazole 2s, which worked with decent to good yields (Scheme ). Other tested N-heterocycles fell into the category of unsuitable substrates (3a–3h, SI), being either unreactive, stopping at hydroxylamine intermediate stage (3d, Scheme ), or leading to side products and oligomerization, which limit the scope of the method.
Scheme 3

Synthesis of Hydroxylamine and Nitrone

Interestingly, for 1-acyl-4-nitroindazole 3d and nitrobenzene 4,very good yields (79%) of hydroxylamine 3d′ and (54%) nitrone 5, respectively, were obtained instead of their amine products (Scheme ). Therefore, we decided to study the reaction mechanism to understand why the reaction is not driven to amine formation in these cases. First, the mechanism of the photoreduction was studied by monitoring the conversion of 1c to 2c with NMR. Hydroxylamine intermediate (1c′) was increasingly formed and consumed in the course of the reaction (Figures a and 3 and SI) in accordance with the previously proposed mechanism for the nitrobenzene reduction.[16,17] The acquired NMR data showed no traces of other species, indicating that the reduction proceeds via the direct route (Figure a and SI) rather than through the condensation of hydroxylamine and nitroso intermediates (Figure b).
Figure 2

(a) Schematic representation of the nitro reduction to amine. (b) Condensation intermediates.

Figure 3

Conversion of 1c to 2c via observed hydroxylamine intermediate 1c′ followed by 1H NMR monitoring (SI). Structures are presented in Figure a.

(a) Schematic representation of the nitro reduction to amine. (b) Condensation intermediates. Conversion of 1c to 2c via observed hydroxylamine intermediate 1c′ followed by 1H NMR monitoring (SI). Structures are presented in Figure a. Initially, we considered the first step of the mechanism to be reduction of substrate, or protonation of the substrate followed by its reduction. However, Stern–Volmer measurements pointed out that a 1:1 mixture of 1k/AscH2 was a superior quencher of [*Ru2+] compared to either of the components alone, indicating their cooperative role (SI). Furthermore, the computed oxidation potentials indicate oxidation of ascorbic acid with [*Ru2+] to be an endergonic process (17.5 kcal/mol, SI), and neither do the experimentally observed yields correlate with the computed reduction potentials of the protonated or nonprotonated substrates (see SI for E°red and E°red,H+ values). Therefore, we propose the mechanism depicted in Figure a: (A) the reaction is initiated by a multisite proton-coupled electron transfer (MS-PCET)[18] between the nitro quinoline, AscH2, and [*Ru2+], i.e., proton and electron are transferred from one donor to two separate acceptors. This is supported by Stern–Volmer titrations for 1k and nitrobenzene (4), in which concentrations of these substrates were fixed and the amount of AscH2 was varied (Figure ). The nonlinear behavior in both cases indicates an MS-PCET-type reaction as suggested by Qiu and Knowles.[18b] Next, (B) the protonated nitro substrate is reduced by [Ru+]: reduction of protonated nitro compound with [Ru+] is a more exergonic process (ΔG ≤ −15.9 kcal/mol) than with [*Ru2+] (−12.7 [1g] ≤ ΔG ≤ −0.9 [3d] kcal/mol), and reduction of [*Ru2+] to [Ru+] by AscH– is an exergonic process (−8.3 kcal/mol). The protonation energies of reactive nitro substrates by AscH2 were calculated to vary between thermoneutral (0.7 kcal/mol for 1c) and endergonic (15.4 kcal/mol for 3d), where the endergonicity of protonation does not exclude hydrogen-bonding interactions between acid and base, which in turn can facilitate MS-PCET reactions.[18]
Figure 4

Modified Stern–Volmer titration, where [Ru] and quencher 1k or 4 were kept constant and AscH2 quencher was varied.

Modified Stern–Volmer titration, where [Ru] and quencher 1k or 4 were kept constant and AscH2 quencher was varied. The protonation of hydroxylamine (C) and the subsequent reduction of [*Ru2+] to [Ru+] by AscH– (D) are required for the reduction of the substrate by [Ru+] (E, Figure a), as the reduction of electron-rich hydroxylamine quinolines would be endergonic with *Ru(bpy)32+ (ΔG ≥ 27.9 kcal/mol, SI). The pKaH values for unreactive hydroxylamine intermediates of 3d and 4 indicates that the protonation is endergonic: 10.1 kcal/mol for 3d′ and 8.9 kcal/mol for 4′. In turn, the reactive hydroxylamine intermediates are easily protonated (C, Figure a) with free energies of −0.8, 2.4, and 2.0 kcal/mol for 1c, 1d, and 1g, respectively. The reduction of protonated hydroxylamine quinolines would be endergonic with [*Ru2+] (4.8 ≤ ΔG ≤ 12.5 kcal/mol, SI), while the process is exergonic with the obtained ground state [Ru+] (ΔG ≤ −2.5 kcal/mol, SI). In summary, we have developed a chemoselective and green photoreductive protocol for reduction of nitro N-heteroaryls that exploits AscH2 as hydrogen source. The method complements the existing photoredox catalysis protocols, extending their applicability for the N-heteroaryls.
  11 in total

1.  The hydrogenation of nitrobenzene to aniline: a new mechanism.

Authors:  Elaine A Gelder; S David Jackson; C Martin Lok
Journal:  Chem Commun (Camb)       Date:  2004-12-02       Impact factor: 6.222

Review 2.  Visible light photoredox catalysis with transition metal complexes: applications in organic synthesis.

Authors:  Christopher K Prier; Danica A Rankic; David W C MacMillan
Journal:  Chem Rev       Date:  2013-03-19       Impact factor: 60.622

3.  Organic Photoredox Catalysis.

Authors:  Nathan A Romero; David A Nicewicz
Journal:  Chem Rev       Date:  2016-06-10       Impact factor: 60.622

4.  Photoreductive Removal of O-Benzyl Groups from Oxyarene N-Heterocycles Assisted by O-Pyridine-pyridone Tautomerism.

Authors:  Aleksandar R Todorov; Tom Wirtanen; Juho Helaja
Journal:  J Org Chem       Date:  2017-11-27       Impact factor: 4.354

5.  Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials.

Authors:  P Loria; S Miller; M Foley; L Tilley
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

6.  Photorelease of primary aliphatic and aromatic amines by visible-light-induced electron transfer.

Authors:  Joseph B Edson; Liam P Spencer; James M Boncella
Journal:  Org Lett       Date:  2011-11-02       Impact factor: 6.005

Review 7.  Primaquine revisited six decades after its discovery.

Authors:  Nuno Vale; Rui Moreira; Paula Gomes
Journal:  Eur J Med Chem       Date:  2008-09-11       Impact factor: 6.514

8.  Rate-Driving Force Relationships in the Multisite Proton-Coupled Electron Transfer Activation of Ketones.

Authors:  Guanqi Qiu; Robert R Knowles
Journal:  J Am Chem Soc       Date:  2019-02-01       Impact factor: 15.419

9.  Photoredox Catalysis in Organic Chemistry.

Authors:  Megan H Shaw; Jack Twilton; David W C MacMillan
Journal:  J Org Chem       Date:  2016-08-01       Impact factor: 4.354

Review 10.  Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.

Authors:  Jonathan Berman; Tracey Brown; Geoffrey Dow; Stephen Toovey
Journal:  Malar J       Date:  2018-11-06       Impact factor: 2.979

View more
  3 in total

1.  Structure-Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors.

Authors:  Andreas Beuchel; Dina Robaa; Dereje A Negatu; Abdeldjalil Madani; Nadine Alvarez; Matthew D Zimmerman; Adrian Richter; Lea Mann; Sophie Hoenke; René Csuk; Thomas Dick; Peter Imming
Journal:  ACS Med Chem Lett       Date:  2022-02-28       Impact factor: 4.345

Review 2.  Photochemical and Electrochemical Applications of Proton-Coupled Electron Transfer in Organic Synthesis.

Authors:  Philip R D Murray; James H Cox; Nicholas D Chiappini; Casey B Roos; Elizabeth A McLoughlin; Benjamin G Hejna; Suong T Nguyen; Hunter H Ripberger; Jacob M Ganley; Elaine Tsui; Nick Y Shin; Brian Koronkiewicz; Guanqi Qiu; Robert R Knowles
Journal:  Chem Rev       Date:  2021-11-23       Impact factor: 60.622

3.  Direct Amination of Nitroquinoline Derivatives via Nucleophilic Displacement of Aromatic Hydrogen.

Authors:  Jakub Wantulok; Daniel Swoboda; Jacek E Nycz; Maria Książek; Joachim Kusz; Jan Grzegorz Małecki; Vladimír Kubíček
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.